Overview

VitamIn and oXygen Interventions and Cardiovascular Events

Status:
Completed
Trial end date:
2020-03-24
Target enrollment:
Participant gender:
Summary
This study examines the risks and benefits of antioxidants and normal versus high inspiratory oxygen fraction during anaesthesia.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital Bispebjerg and Frederiksberg
Treatments:
Acetylcysteine
Antioxidants
Ascorbic Acid
N-monoacetylcystine